A pickthewinner clinical trial design in metastatic triple negative breastcancer patients shows immune induction with chemotherapy improves clinical responses to PD1 blockade httpgo.nature.com2Q5gjLv NKInlpic.twitter.comJ58Jtx0ds5

A pick-the-winner clinical trial design in metastatic triple negative #breastcancer patients shows immune induction with #chemotherapy improves clinical responses to #PD-1 blockade| http://go.nature.com/2Q5gjLv  | @NKI_nlpic.twitter.com/J58Jtx0ds5

10:00 EDT 16 May 2019 | Nature Publishing

A pick-the-winner clinical trial design in metastatic triple negative #breastcancer patients shows immune induction with #chemotherapy improves clinical responses to #PD-1 blockade| http://go.nature.com/2Q5gjLv  | @NKI_nl pic.twitter.com/J58Jtx0ds5

More From BioPortfolio on "A pick-the-winner clinical trial design in metastatic triple negative #breastcancer patients shows immune induction with #chemotherapy improves clinical responses to #PD-1 blockade| http://go.nature.com/2Q5gjLv  | @NKI_nlpic.twitter.com/J58Jtx0ds5"